Federal Register / Vol. 86, No. 194 / Tuesday, October 12, 2021 / Notices 56711 

TABLE 2—TABLE OF OUTCOMES—Continued 

Category 

IPV .................................................. 

Included outcomes 

Æ STI incidence (based on testing/biologic confirmation). 

Æ STI complications. 

• Behavioral outcomes: 

Æ Changes in STI risk behaviors (e.g., multiple sexual partners, concurrent sexual partners, sexual 

partners with high STI risk, unprotected sexual intercourse or contact, sex while intoxicated with alcohol or other substances, sex in exchange for money or drugs). 

Æ Changes in protective behaviors (e.g., sexual abstinence; mutual monogamy; delayed initiation of 

intercourse or age of sexual debut; use of condoms, other barrier methods, or chemical barriers; or 

other changes in sexual behavior). 

• STI harms: 

Æ Health care avoidance. 

Æ Psychological harms (e.g., anxiety, shame, guilt, stigma). 

• Health outcomes: 

Æ Reduced exposure to IPV as measured by a validated instrument (e.g., Community Composite 

Scale), self-report frequency of abuse (e.g., number of physical/sexual assaults), or discontinuation 

of an unsafe relationship. 

Æ Physical morbidity caused by IPV, including acute physical trauma (e.g., fractures, dislocations). 

Æ Mental health morbidity caused by IPV, including acute mental morbidity (e.g., stress, nightmares) 

and chronic mental health conditions (e.g., posttraumatic stress disorder, anxiety, depression). 

Æ Sexual trauma, unintended pregnancy, pregnancy loss, and sexually transmitted infections. 

Æ Health care utilization attributed to physical or mental effects of IPV (e.g., rates of emergency room 

visits). 

Æ Social isolation. 

• Harms: 

Æ Increased abuse or other forms of retaliation; and other reported harms of screening or identification. 

Abbreviations: IPV = interpersonal violence; KQ = key question; STI = sexually transmitted infections. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–22074 Filed 10–8–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Final Effect of Designation of a Class 

of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice concerning 

the final effect of the HHS decision to 

designate a class of employees from the 

Savannah River Site in Aiken, South 

Carolina, as an addition to the Special 

Exposure Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Grady Calhoun, Director, Division of 

Compensation Analysis and Support, 

NIOSH, 1090 Tusculum Avenue, MS C– 

46, Cincinnati, OH 45226–1938, 

Telephone 513–533–6800. Information 

requests can also be submitted by email 

to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: On August 

18, 2021, as provided for under 42 

U.S.C. 7384l(14)(C), the Secretary of 

HHS designated the following class of 

employees as an addition to the SEC: 

All construction trade employees of 

Department of Energy subcontractors 

[excluding employees of the following prime 

contractors who worked at the Savannah 

River Site in Aiken, South Carolina, during 

the specified time periods: E. I. du Pont de 

Nemours and Company, October 1, 1972, 

through March 31, 1989; and Westinghouse 

Savannah River Company, April 1, 1989, 

through December 31, 1990], who worked at 

the Savannah River Site from October 1, 

1972, through December 31, 1990, for a 

number of work days aggregating at least 250 

work days, occurring either solely under this 

employment or in combination with work 

days within the parameters established for 

one or more other classes of employees 

included in the Special Exposure Cohort. 

This designation became effective on 

September 17, 2021. Therefore, 

beginning on September 17, 2021, 

members of this class of employees, 

defined as reported in this notice, 

became members of the SEC. 

Authority: 42 U.S.C. 7384q(b). 42 

U.S.C. 7384l(14)(C). 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2021–22132 Filed 10–8–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–0966] 

Closer to Zero Action Plan: Impacts of 

Toxic Element Exposure and Nutrition 

at Different Crucial Developmental 

Stages; Public Meeting; Request for 

Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting; 

request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing the following virtual public 

meeting entitled ‘‘Closer to Zero Action 

Plan: Impacts of Toxic Element 

Exposure and Nutrition at Different 

Crucial Developmental Stages.’’ The 

purpose of the public meeting is to 

discuss the scope of the Closer to Zero 

action plan as it relates to the impacts 

of toxic element exposure and nutrition 

at different crucial developmental 

stages, including discussion of the key 

nutrients in food for growth and 

development, foods commonly 

consumed by babies and young 

children, and exposure risks of toxic 

elements. 

DATES: The public meeting will be held 

on November 18, 2021, from 10 a.m. to 

4 p.m. Eastern Time. FDA is